Intervention Review

Depot fluspirilene for schizophrenia

  1. Akhil Abhijnhan1,*,
  2. Clive E Adams2,
  3. Anthony David3,
  4. Mehmet Ozbilen4

Editorial Group: Cochrane Schizophrenia Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 14 NOV 2006

DOI: 10.1002/14651858.CD001718.pub2

How to Cite

Abhijnhan A, Adams CE, David A, Ozbilen M. Depot fluspirilene for schizophrenia. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD001718. DOI: 10.1002/14651858.CD001718.pub2.

Author Information

  1. 1

    Kalyan, Kochi, Kerala, India

  2. 2

    The University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

  3. 3

    Institute of Psychiatry, London, UK

  4. 4

    Leeds Mental Health Trust, Leeds, West Yorkshire, UK

*Akhil Abhijnhan, Kalyan, M.K.K.Nair Road, Palarivattom, Kochi, Kerala, 682025, India.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2007


  1. Current Version

    Depot fluspirilene for schizophrenia

    Akhil Abhijnhan, Clive E Adams, Anthony David and Mehmet Ozbilen

    Article first published online: 24 JAN 2007 | DOI: 10.1002/14651858.CD001718.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Depot fluspirilene for schizophrenia

    A David, CE Adams and SN Quraishi

    Article first published online: 26 JUL 1999 | DOI: 10.1002/14651858.CD001718